Cellectar Biosciences Ownership | Who Owns Cellectar Biosciences?
Cellectar Biosciences Ownership Summary
100.00% retail investors. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.64% of its assets in Cellectar Biosciences shares.
CLRB Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Cellectar Biosciences | - | - | 100.00% |
Sector | Healthcare Stocks | 47.06% | 8.01% | 44.93% |
Industry | Biotech Stocks | 44.97% | 7.82% | 47.21% |
Institutional Shareholders
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Jun 30, 2023 | 1 | - | 5 | - | - | - | - | -100.00% | - | - |
Mar 31, 2023 | 1 | - | 5 | - | - | - | 1 | - | - | - |
Sep 30, 2022 | 1 | -96.43% | 5 | -100.00% | - | - | - | -100.00% | - | -100.00% |
Jun 30, 2022 | 28 | - | 6,561,180 | -3.30% | 107 | 0.87% | 9 | 28.57% | 6 | 50.00% |
Mar 31, 2022 | 28 | -20.00% | 6,784,960 | 3.48% | 111 | 0.80% | 7 | -50.00% | 4 | -33.33% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Vanguard Total Stock Mkt Idx Inv | 1.07M | 2.64% | - |
Vanguard Institutional Extnd Mkt Idx Tr | 568.75K | 1.40% | - |
Fidelity Extended Market Index | 183.91K | 0.45% | 567.00 |
iShares Micro-Cap ETF | 81.91K | 0.20% | - |
BlackRock Extended Equity Market K | 72.26K | 0.20% | -31.00 |
Fidelity Total Market Index | 62.15K | 0.15% | -10.15K |
Fidelity Series Total Market Index | 42.43K | 0.10% | 9.84K |
Vanguard Balanced Index Inv | 37.50K | 0.09% | - |
Northern Trust Extended Eq Market Idx | 32.17K | 0.09% | - |
NT Ext Equity Mkt Idx Fd - L | 32.17K | 0.09% | - |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Sep 14, 2021 | Swirsky Douglas J | - | Buy | $26.00K |
Sep 03, 2021 | DRISCOLL FREDERICK W | - | Buy | $20.24K |
Mar 17, 2021 | NEIS JOHN | - | Sell | $1.78M |
Mar 18, 2021 | NEIS JOHN | - | Sell | $706.25K |
Mar 12, 2021 | NEIS JOHN | - | Sell | $1.25M |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2023 Q2 | - | - |
2023 Q1 | - | - |
2022 Q4 | - | - |
2022 Q2 | - | - |
2022 Q1 | - | - |
CLRB Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools